Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25µg/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Medconsult Services Limited
Manufacturer: Chiron S.r.l, Bellaria, Rosia, Sovicille, Italy
Note: This consent is valid for two years from 8 July 2006.
Dated this 19th day of July 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).